- Sputnik International
Get the latest news from around the world, live coverage, off-beat stories, features and analysis.

PM Modi Reviews COVID Vaccine Preparedness Day After India's First Candidate Enters Clinical Trial

© REUTERS / Dado RuvicSmall bottles labeled with a "Vaccine COVID-19" sticker and a medical syringe are seen in this illustration taken taken April 10, 2020
Small bottles labeled with a Vaccine COVID-19 sticker and a medical syringe are seen in this illustration taken taken April 10, 2020 - Sputnik International
New Delhi (Sputnik): India is the second most populous country in the world and faces the challenge of efficiently conducting a vaccination programme among its highly diverse population.

Indian Prime Minister Narendra Modi held a meeting on Tuesday to review preparations and planning for a vaccination programme once a COVID-19 vaccine becomes available.

The high-level meeting comes a day after India's first COVID-19 vaccine candidate, COVAXIN, secured approval to enter clinical trials.

The prime minister discussed a plan that stipulates that vulnerable groups, which include health care workers, should be identified and prioritized for early vaccination.

He also emphasised that there would be no domicile-related restrictions for getting a vaccine and said that the vaccine must be affordable and accessible through the use of technology.

The prime minister invited suggestions for available technology options which could be deployed to support the programme.

India's first vaccine candidate developed by biotechnology firm Bharat Biotech in collaboration with the Indian Council for Medical Research and the National Institute of Virology, will start conducting Phase I and II clinical trials after the pre-clinical studies showed "promising results" and "effective" immune responses.

The Serum Institute of India has already reached a licensing agreement with AstraZeneca to produce a vaccine which is currently undergoing trials at the University of Oxford.

To participate in the discussion
log in or register
Заголовок открываемого материала